Tenet Healthcare (THC) to Release Quarterly Earnings on Tuesday

Tenet Healthcare (NYSE:THC) will likely be releasing its Q2 2025 earnings data before the market opens on Tuesday, July 22nd. Analysts expect Tenet Healthcare to post earnings of $2.84 per share and revenue of $5.16 billion for the quarter. Tenet Healthcare has set its FY 2025 guidance at 11.990-13.120 EPS.

Tenet Healthcare (NYSE:THC) last released its earnings results on Tuesday, April 29th. The company reported $4.36 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $3.11 by $1.25. Tenet Healthcare had a return on equity of 22.58% and a net margin of 7.09%. The business had revenue of $5.22 billion during the quarter, compared to the consensus estimate of $5.15 billion. During the same period last year, the business posted $3.22 earnings per share. The business’s revenue for the quarter was down 2.5% on a year-over-year basis. On average, analysts expect Tenet Healthcare to post $12 EPS for the current fiscal year and $13 EPS for the next fiscal year.

Tenet Healthcare Stock Performance

NYSE:THC opened at $177.73 on Tuesday. The company has a market capitalization of $16.51 billion, a P/E ratio of 11.75, a P/E/G ratio of 1.28 and a beta of 1.64. Tenet Healthcare has a 1 year low of $109.82 and a 1 year high of $178.76. The company has a debt-to-equity ratio of 2.23, a current ratio of 1.78 and a quick ratio of 1.70. The business has a fifty day simple moving average of $165.94 and a two-hundred day simple moving average of $142.64.

Analyst Upgrades and Downgrades

THC has been the subject of several recent research reports. Royal Bank Of Canada lifted their price target on Tenet Healthcare from $183.00 to $189.00 and gave the company an “outperform” rating in a research report on Wednesday, April 30th. Wells Fargo & Company raised Tenet Healthcare from an “equal weight” rating to an “overweight” rating and lifted their price target for the stock from $150.00 to $195.00 in a research note on Thursday, May 29th. Barclays lifted their price target on Tenet Healthcare from $171.00 to $215.00 and gave the stock an “overweight” rating in a research note on Monday, June 2nd. The Goldman Sachs Group boosted their target price on Tenet Healthcare from $134.00 to $154.00 and gave the company a “neutral” rating in a research note on Monday, May 5th. Finally, Stephens upgraded Tenet Healthcare to a “strong-buy” rating in a report on Monday, June 2nd. Three analysts have rated the stock with a hold rating, sixteen have given a buy rating and one has issued a strong buy rating to the company. Based on data from MarketBeat.com, Tenet Healthcare currently has an average rating of “Moderate Buy” and a consensus price target of $184.53.

Insider Buying and Selling

In related news, Director Richard W. Fisher sold 836 shares of the company’s stock in a transaction that occurred on Thursday, June 5th. The stock was sold at an average price of $173.16, for a total value of $144,761.76. Following the transaction, the director directly owned 11,292 shares of the company’s stock, valued at approximately $1,955,322.72. This represents a 6.89% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. Also, Director J Robert Kerrey sold 1,222 shares of the stock in a transaction on Tuesday, May 27th. The shares were sold at an average price of $164.96, for a total value of $201,581.12. Following the sale, the director owned 22,377 shares in the company, valued at approximately $3,691,309.92. This represents a 5.18% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold a total of 54,121 shares of company stock worth $8,846,305 over the last three months. Corporate insiders own 0.81% of the company’s stock.

Institutional Trading of Tenet Healthcare

A hedge fund recently raised its stake in Tenet Healthcare stock. NewEdge Advisors LLC boosted its holdings in shares of Tenet Healthcare Corporation (NYSE:THC) by 6.1% during the 1st quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 2,890 shares of the company’s stock after purchasing an additional 166 shares during the quarter. NewEdge Advisors LLC’s holdings in Tenet Healthcare were worth $389,000 at the end of the most recent quarter. Institutional investors and hedge funds own 95.44% of the company’s stock.

About Tenet Healthcare

Tenet Healthcare Corporation operates as a diversified healthcare services company in the United States. The company operates through two segments: Hospital Operations and Services, and Ambulatory Care. Its general hospitals offer acute care services, operating and recovery rooms, radiology and respiratory therapy services, clinical laboratories, and pharmacies.